Cancer

Nabsys Presents Data Detailing OhmX™ Platform’s Unique Advantages of Genome Mapping at American Society of Human Genetics (ASHG) 2025 Annual Meeting

Electronic genome mapping (EGM) detects and validates structural variants in cancer genomes with improved accuracy over existing platforms, including optical…

4 months ago

Sona Nanotech To Host Investor Webinar To Discuss Clinical Study

Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces…

4 months ago

Montefiore Einstein and Dandelion Partner to Accelerate AI-Driven Drug Development and New Clinical Care Solutions

BRONX, N.Y., Oct. 17, 2025 /PRNewswire/ -- Montefiore Einstein and Dandelion Health, Inc. ("Dandelion") have announced a strategic partnership to advance…

4 months ago

NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension

NEW YORK, Oct. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

4 months ago

Nabsys Presents Novel Disease Insights and Advantages in Structural Variant Detection using OhmX™ Platform at American Society of Human Genetics (ASHG) 2025 Annual Meeting

Multi-omics study utilizing electronic genome mapping (EGM) reveals 70% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) have psychiatric comorbidities…

4 months ago

Eon Further Establishes Leadership Position in Early Detection and Management of Incidental Findings, Announces Half a Billion Radiology Reports Analyzed

Specialized clinical AI and extensive real-world experience enable early diagnosis across 75+ health systems DENVER, Oct. 16, 2025 /PRNewswire/ -- Eon,…

4 months ago

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH),…

4 months ago

Genomics launches Mystra: the world’s first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development

The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes,…

4 months ago

Volpara Earns ACR® Learning Network Vendor Partner Designation

LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ -- Volpara Health has qualified for the American College of Radiology® (ACR®) Learning Network…

4 months ago

Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery

Backed by a $7.8M award from the National Science Foundation, Caravel unlocksbreakthroughs across animal health, biochemical manufacturing, and beyond. PORTLAND,…

4 months ago